Analyst Price Targets — CMT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 11, 2026 12:16 pm | Chip Moore | Roth Capital | $24.00 | $18.48 | TheFly | Core Molding price target raised to $24 from $22 at Roth Capital |
| March 12, 2025 12:02 pm | Chip Moore | Roth Capital | $22.00 | $13.32 | TheFly | Core Molding price target lowered to $22 from $24 at Roth MKM |
| March 13, 2024 7:07 am | Tim Moore | EF Hutton | $27.00 | $19.19 | StreetInsider | Core Molding Technologies (CMT) PT Raised to $27 at EF Hutton |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CMT

COLUMBUS, Ohio, July 14, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty trucks, powersports, building products, and industrial and utility industries across North America, today announces that it will release its second…

COLUMBUS, Ohio, July 07, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utility industries across the United States, Canada, and Mexico, today announced the…

Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2a SYNAPSE-CMT exploratory study evaluating ignaseclant in patients living with Charcot-Marie-Tooth disease (CMT) types 1 or 2 has been presented in a late-breaking oral presentation at…

VANCOUVER, BC – TheNewswire - June 01, 2026 – Cullinan Metals Corp. (the “Company”) (CSE: CMT) (OTCQB: CNTMF) (FSE: 7KO) is pleased to announce the launch of its new corporate website, reflecting the Company's evolving strategic direction and renewed focus on emerging resource opportunities and advanced technologies. The new website is now available at: www.cullinanmetalscorp.com

Core Molding Technologies reported 1Q26 results showing pressured trucking revenues offset by strength in industrial, EV, and BESS segments. CMT maintains robust gross margins (~20%) and expects 17–19% for the year, with adjusted operating income potentially reaching $20 million in 2026. Management anticipates a trucking cycle recovery and sales upside from the expanded Matamoros facility in 2H26, but near-term…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CMT.
U.S. House Trading
No House trades found for CMT.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
